Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individualization of Oral Mesalazine Treatment Through a Self-managed Web-based Solution in Mild-to-moderate Ulcerative Colitis: A Pilot Study

NCT03604536 is registered in ClinicalTrials.gov with Nordsjaellands Hospital as lead sponsor.

NCT NCT03604536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03604536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individualization of Oral Mesalazine Treatment Through a Self-managed Web-based Solution in Mild-to-moderate Ulcerative Colitis: A Pilot Study
Lead sponsor
Nordsjaellands Hospital
Phase
Observational
Overall status
Terminated
Start date
December 2, 2019
Completion date
December 31, 2021
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel diseases, ulcerative colitis